EUVIMEDEUVIMED entdecken
Open Access

Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin

Pasha A Davoudian iD, Ling-Xiao Shao, Alex C Kwan iD

ACS Chemical Neuroscience · 01.02.2023 · 14 (3) · 468-480

DOI: 10.1021/acschemneuro.2c00637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 11.01.2023. Verfasst von Pasha A Davoudian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, Yale University School of Medicine, New Haven, Connecticut 06511, United States. Hauptthemen laut MEDLINE: Ketamine, Hallucinogens. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIGMS NIH HHS, One Mind.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psilocybin is a psychedelic with therapeutic potential. While there is growing evidence that psilocybin exerts its beneficial effects through enhancing neural plasticity, the exact brain regions involved are not completely understood. Determining the impact of psilocybin on plasticity-related gene expression throughout the brain can broaden our understanding of the neural circuits involved in psychedelic-evoked neural plasticity. In this study, whole-brain serial two-photon microscopy and light sheet microscopy were employed to map the expression of the immediate early gene, c-Fos, in male and female mice. The drug-induced c-Fos expression following psilocybin administration was compared to that of subanesthetic ketamine and saline control. Psilocybin and ketamine produced acutely comparable elevations in c-Fos expression in numerous brain regions, including anterior cingulate cortex, locus coeruleus, primary visual cortex, central and basolateral amygdala, medial and lateral habenula, and claustrum. Select regions exhibited drug-preferential differences, such as dorsal raphe and insular cortex for psilocybin and the CA1 subfield of hippocampus for ketamine. To gain insights into the contributions of receptors and cell types, the c-Fos expression maps were related to brain-wide in situ hybridization data. The transcript analyses showed that the endogenous levels of Grin2a and Grin2b predict whether a cortical region is sensitive to drug-evoked neural plasticity for both ketamine and psilocybin. Collectively, the systematic mapping approach produced an unbiased list of brain regions impacted by psilocybin and ketamine. The data are a resource that highlights previously underappreciated regions for future investigations. Furthermore, the robust relationships between drug-evoked c-Fos expression and endogenous transcript distributions suggest glutamatergic receptors as a potential convergent target for how psilocybin and ketamine produce their rapid-acting and long-lasting therapeutic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineHallucinogensMaleFemaleMiceAnimalsPsilocybinGenes, Immediate-EarlyBrainProto-Oncogene Proteins c-fosDorsal Raphe Nucleus

Stichwörter der Autor:innen

activity-dependent transcriptionantidepressantc-Fosimmediate early geneneural plasticitypsychedelics

Substanzen

KetaminePsilocybinHallucinogensProto-Oncogene Proteins c-fos

Autor:innen und Institutionen

  • Medical Scientist Training Program, Yale University School of Medicine, New Haven, Connecticut 06511, United States.
  • Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, Connecticut 06511, United States.
  • Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06511, United States.
  • Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
  • Department of Neuroscience, Yale University School of Medicine, New Haven, Connecticut 06511, United States.
  • Department of Psychiatry, Weill Cornell Medicine, New York, New York 10065, United States.

ORCID-Profile: Pasha A Davoudian, Alex C Kwan

Förderung

  • NIMH NIH HHS
  • NIGMS NIH HHS
  • One Mind
  • National Institute of Mental Health
  • National Institute of General Medical Sciences
  • Usona Institute

Zitieren

APA

Davoudian, P. A., Shao, L. X., & Kwan, A. C. (2023). Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin. ACS Chemical Neuroscience, 14(3), 468-480. https://doi.org/10.1021/acschemneuro.2c00637

Vancouver

Davoudian PA, Shao LX, Kwan AC. Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin. ACS Chemical Neuroscience. 2023;14(3):468-480. doi:10.1021/acschemneuro.2c00637

BibTeX
@article{Davoudian2023,
  author = {Davoudian, Pasha A and Shao, Ling-Xiao and Kwan, Alex C},
  title = {Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin},
  journal = {ACS Chemical Neuroscience},
  year = {2023},
  volume = {14},
  number = {3},
  pages = {468--480},
  doi = {10.1021/acschemneuro.2c00637}
}
Kostenlos starten →